Atossa Therapeutics, Inc.
ATOS· Nasdaq
Atossa Therapeutics, Inc.
- Last sale
- Oct 1, 2026 · +15.82%
- Market cap
- $22.65M
- 9.98M shares
- Filings
- 640
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2015 | 2015-12-31 | $1,758 | reported | |
| FY 2014 | 2014-12-31 | $40,138 revised | reported | |
| FY 2013 | 2013-12-31 | $632,558 | reported | |
| FY 2012 | 2012-12-31 | $481,842 | reported | |
| FY 2011 | 2011-12-31 | $1,500 | reported |
Atossa Therapeutics, Inc. · CIK 1488039 · Engraved from SEC EDGAR
